share_log

益方生物:一审判决驳回原告米拉蒂公司全部诉讼请求

Yifang Bio: The first-instance judgment dismissed all the litigation requests of the plaintiff Mirati Company.

Breakings ·  Sep 29 17:25

Announcement from Yifang Bio, the company and its wholly-owned subsidiary Yifang USA, Director XING DAI (Star Dai) have received the "Civil Judgment" from the Shanghai Intellectual Property Court for the lawsuit involving the infringement of technical secrets of Milati Company and Yaray Company. The first-instance court rejected all the plaintiff's litigation requests. The amount involved is 99 million yuan. This lawsuit will not have a negative impact on the company's profits and losses, but this judgment is a first-instance judgment and is still within the appeal period. The company will closely monitor the follow-up situation of the case and fulfill the obligation of information disclosure in a timely manner.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment